Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • boilerroommanager boilerroommanager Jun 18, 2013 3:15 PM Flag

    Market Authority Just Sent Out This Mass Mailer About Belviq/Consumer Report (from IV board)

    Market Authority Just Sent Out This Mass Mailer About Belviq/Consumer Report
    What Consumer Reports Fails to Understand...
    Presented by Ian L. Cooper
    Speed Retirement System

    Perhaps Consumer Reports doesn't understand its target audience ...

    "We've long cautioned against taking quick-fix weight-loss drugs like Belviq, and Qsymia -- that was also approved by the FDA last year--as well as supplements, because their benefits are usually minimal, and their adverse effects can be troublesome. Instead, skip the pills, and lose weight the safer, tried-and-true way--by eating less and exercising," reports the well-respected organization.

    Eating less and exercising... What a novel idea.

    Why haven't weight loss clinics, physicians, television programs, nutritionists, and gyms thought of that?

    There's a reason that 66.3% of Americans are either overweight and / or obese.

    These people don't exercise much or at all... and they obviously don't diet.

    Many overweight and obese Americans would rather pop a pill than pant on a treadmill for 10 minutes a day.

    That's the cold hard truth...

    Consumer Reports then bashes Belviq for its "slim results" of just 3% to 3.7% weight loss.

    However "weight loss in overweight/obese persons of as little as 3% to 5% of body weight has shown improvements in high-density lipoproteins (the good cholesterol), glucose metabolism, a decrease in triglycerides (blood fats) and other risk factors of cardiovascular disease," according to studies from The American College of Sports Medicine (ACSM).

    "Health improvements in chronic disease risk factors can be realized with as little as a 2- to 3-percent reduction in excess body weight."

    So much for that "slim results" bash.

    Consumer Reports then tells us about "risks galore."

    These include "headache, dizziness, fatigue, nausea, dry mouth and constipation."

    That's quite interesting.

    One, every drug in existence must report every side effect that patients have. It doesn't mean every one is going to h

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ARNA
1.77-0.04(-2.21%)1:30 PMEDT